| Literature DB >> 31406807 |
Mengjie Lei1, Tingting Liu1, Yufeng Li1, Yaqian Liu1, Lina Meng1, Changde Jin1.
Abstract
OBJECTIVE: This meta-analysis aims to systematically evaluate the effects of massage on infants with jaundice.Entities:
Keywords: Jaundice; Massage; Meta-analysis; Neonate
Year: 2018 PMID: 31406807 PMCID: PMC6626238 DOI: 10.1016/j.ijnss.2018.01.004
Source DB: PubMed Journal: Int J Nurs Sci ISSN: 2352-0132
Fig. 1Flow chart of the study selection procedure.
Abbreviations: CBM: China Biology Medicine; CNKI: China National Knowledge Infrastructure; VIP: VIP Database for Chinese Technical Periodicals; RCT: randomized controlled trial.
Characteristics of included studies.
| First author, y | Inclusion and exclusion criteria | Type of study | Sample size(I/C) | Interventions | Outcome |
|---|---|---|---|---|---|
| Sun Yunhai et al., 2004 | Inclusion and exclusion criteria are not reported | RCT | 105/105 | Massage(once/d, every 15 min, until the 42nd days of birth) | ①; ②; ⑤ |
| Wei Lin'an et al., 2007 | inclusion criteria: a1,b,c1,d,f,g; | RCT | 34/34 | massage(2 times/d, every 15 min) | ②; ④; ⑤ |
| Cheng Shuang et al., 2015 | inclusion criteria: a1,d,k,l,n; | RCT | I1/I2/I3/C = 73/72/71/70 | massage(2 times/d, every 20 min) | ⑤; ⑥; ⑦; ⑧ |
| Liu Shanshan et al., 2013 | inclusion criteria: a1,c2,o,p; | RCT | 40/40 | massage(2 times/d, every 10–15 min) | ②; ⑤; ⑦ |
| Lai Shuying et al., 2017 | inclusion criteria: a1,c2,o,p; | RCT | 285/285 | massage(2 times/d, every 15–20 min, until the 7th days of birth) | ③; ⑤ |
| Zhang Ying et al., 2012 | inclusion criteria: c2,d; | RCT | 90/90 | massage(2 times/d, every 15 min) | ①; ②; ④; ⑤; ⑦; ⑧ |
| Wu Jing,2013 | inclusion criteria: a1,q,r,h,l; | RCT | 50/50 | massage(2 times/d, every 15–20 min, until the 5th days of birth) | ①; ②; ⑤; ⑦; ⑧; ⑨ |
| Ye Liying et al., 2015 | inclusion criteria: d,n,i; | RCT | 58/58 | massage(once/d, every 15–20 min) | ②; ⑤; ⑦ |
| Lai Ai-ru et al., 2016 | inclusion criteria: l; | RCT | 50/50 | massage(2 times/d, every 30 min, until the 4th days of birth) | ⑤; ⑦ |
| Hosein Dalili et al., 2015 | inclusion criteria: a1,c3,d,l; | RCT | 25/25 | massage(3 times/d, every 15–20 min, until the 4th days of birth) | ⑤; ⑦ |
| Lin, Chien-Heng et al., 2015 | inclusion criteria: a1,c4,d,x; | RCT | 27/29 | massage(2 times/d, every 15–20 min, until the 3th days of birth) | ①; ⑤; ⑦; ⑧; ⑩ |
| Alehe Seyyedrasooli et al., 2014 | inclusion criteria: j,l; | RCT | 26/28 | massage(3 times/d, every 15 min, until the 4th days of birth) | ⑤; ⑦ |
| Jun Chen et al., 2011 | inclusion criteria: a1,c3,d; | RCT | 20/22 | massage(2 times/d, every 15–20 min, until the 5th days of birth) | ⑤; ⑦ |
| Mahdi BasiriMoghadam et al., 2015 | inclusion criteria: a2,c5,d,l,p; | RCT | 20/20 | massage(2 times/d, every 20 min, until the 4th days of birth) | ⑤; ⑦ |
a1:term infan; a2:infant at 34–36 weeks of gestational; b:infant of 1–28 days of birth; c1:birth weight:2.5–3.5 kg; c2:birth weight:2.5–4.0 kg; c3:birth weight:2.8–3.6 kg; c4:birth weight:2.5–3.6 kg; c5:low birth weight; c6:extremely low birth weight; d:Apgar score ≥8; f: hyperbilirubinemia; g:serum bilirubin levels:256μmol/L∼336.8umol/L; h:blood total bilirubin>205.2umol/L; i:It was mainly indirect bilirubin when bilirubin increased; j: percutaneous bilirubin on first day<5 mg/dl; k:rooming-in care; l:breastfeeding; m:There is a simple breast milk contraindications in the newborns; n:There are yellow dye symptoms in the newborns; o:single pregnancy; p:Families agree to participate in the study; q:Meet the diagnostic criteria for neonatal jaundice; r:meet the standard of light therapy; s:Neonatal suffer from congenital diseases and complications (such as neonatal asphyxia, hemolytic symptoms, patent ductus arteriosus (PDA), respiratory distress syndrome (RDS) and sepsis, amniotic fluid inhalation syndrome, birth defects; birth trauma, Asphyxia and infection, etc.); t:Other causes of jaundice (Hepatitis, hemolytic disease, congenital diseases, familial and perinatal factors, infection, uterine bleeding, glucose-6-phosphate dehydrogenation Enzyme deficiency, gastrointestinal obstruction and biliary atresia); u:Pregnant women without diabetes and liver and gall diseases; v:Pregnant women without pregnancy complications; w:Neonatal of needing oxygen supply and respiratory support; x:infants of needing light therapy for jaundice; y:The newborns are at the beginning of the phototherapy; z:Use the drugs of reducing bilirubin; ab:There are the relevant factors of restricting massage in infants(eg: edema, tissue damage, skin infections and rash); ac:Infants had discharged before the study was finished.
I/C:sample size of intervention group/sample size of control group.
①weight; ②sleep condition; ③neonatal neurobehavioral determination; ④crying; ⑤Bilirubin levels and duration; ⑥hepatic function; ⑦Defecation; ⑧breastfeeding condition; ⑨The incidence of adverse reactions; ⑩the time of stopping light therapy and discharging.
Methodological quality for each included study.
| Study | Sequence generation | Allocation concealment | Blinding | Withdraw | Baseline | ITT | Score |
|---|---|---|---|---|---|---|---|
| Sun Haiyun et al. | unclear | high risk | high risk | low risk | low risk | low risk | B |
| Wei LIn'an et al. | unclear | unclear | unclear | low risk | low risk | low risk | A |
| Cheng Shuang et al. | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Liu Shanshan et al. | unclear | high risk | high risk | low risk | low risk | low risk | B |
| Lai Shuying et al. | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Zhang Ying et al. | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Wu Jing | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Ye Liying et al. | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Lai Ai-ru et al. | low risk | high risk | high risk | low risk | low risk | low risk | B |
| Hosein Dalili et al. | unclear | high risk | high risk | low risk | low risk | low risk | B |
| Lin, Chien-Heng et al. | unclear | high risk | high risk | low risk | low risk | low risk | B |
| Alehe Seyyedrasooli et al. | low risk | low risk | high risk | low risk | low risk | low risk | A |
| Jun Chen et al. | unclear | high risk | high risk | high risk | low risk | high risk | B |
| Mahdi BasiriMoghadam et al. | low risk | low risk | low risk | low risk | low risk | low risk | A |
Blinding: whether patients, care providers and outcome assessors were blinded. Intention-to-treat (ITT): whether trial authors performed analyses to take into account all patients who began the intervention regardless of protocol violations, drop-outs or loss of follow-up.
Sequence generation:low risk[Specific random method was reported]; unclear[Random was mentioned, but the specific random method was not reported]; high risk[Random was not mentioned].
Allocation concealment:low risk[Specific method of allocation concealment was reported]; unclear[Allocation concealment was mentioned, but the specific method of allocation concealment was not reported]; high risk[Allocation concealment was not mentioned].
Blinding:low risk[Specific blinding method was reported]; unclear[Blinding was mentioned, but the specific blinding method was not reported]; high risk[Blinding was not mentioned].
Withdraw:low risk[There was no withdraw, or withdraw was properly handled]; unclear[The method of handling withdraw was not clearly reported]; high risk[Withdraw was not handled].
Baseline:low risk[All factors at baseline were comparable]; unclear[Partly factors at baseline were comparable]; high risk[All factors at baseline were not comparable].
ITT:low risk[There was no need for intentional analysis, or appropriate intentional analysis was carried out]; unclear[Intentional analysis is unclear]; high risk[Appropriate intentional analysis was not carried out].
Fig. 6Methodological quality assessment for risk of bias for each included study.
Fig. 2Forest plot of percutaneous bilirubin level.
“Percutaneous bilirubin level on the first/second/third/fourth/seventh day of birth” in Fig. 2 represents percutaneous bilirubin level of being measured when neonatals are on the first/second/third/fourth/seventh day of birth.
Fig. 3Forest plot of serum total bilirubin level.
“Serum total bilirubin level (sample size≥100)”in Fig. 3 represents Serum total bilirubin level of neonatal in studies of sample size ≥ 100.“Serum total bilirubin level (sample size<100)”in Fig. 3 represents serum total bilirubin level of neonatal in studies of sample size<100.
Fig. 4Forest plot of defecation frequency.
Defecation frequency on the first/second/third/fourth day of birth”in Fig. 4 represents defecation frequency of being measured when neonatals are on the first/second/third/fourth day of birth.
Fig. 5Forest plot of defecation frequency.
Defecation frequency on the first/second/third/fourth day of birth”in Fig. 5 represents defecation frequency of being measured when neonatals are on the first/second/third/fourth day of birth.